Cart, 0 Items

Subtotal (USD):$0.00
Your cart is empty
After you’ve made a selection, review it here before checking out.
Search titles
Cover of GUIDE TO BIOSIMILARS LITIGATION AND REGULATION IN THE UNITED STATES SUB
Quick look inside:

Guide To Biosimilars Litigation and Regulation In The United States, 2025-2026 ed.

Publisher:

Author(s):

Goodwin
Format
Purchase option
One-time purchase
One-time purchase of this edition. Updates or new editions must be purchased separately.
$339.00
now
Quantity
Availability:
In stock
Book & eBook - One-time purchase with no updates
$339.00 USD
now

PROVIEW PLUS PRINT PRIMARY GUIDE TO BIOSIMILARS LITIGATION AND REGULATION IN THE US SUB

Format

Book & eBook

Purchase option

One-time purchase with no updates

Quantity

1

Total

$339.00

/now

Product details
Description

Guide to Biosimilars Litigation and Regulation in the U.S. is an understandable guide and go-to reference, providing expert and practical guidance for attorneys working in this burgeoning area of the law.

The title explores each section of the Biologics

Service Number:43375365
Practice area:Intellectual property law
Jurisdiction:National
External Product Title:PROVIEW PLUS PRINT PRIMARY GUIDE TO BIOSIMILARS LITIGATION AND REGULATION IN THE US SUB
Update frequency:As changes in the law dictate
Update Format:N/A
Subscription Number:43375363
Available Formats:Book & eBook, eBook, eBook, Softbound book
Shelf space:0 in
Author:


ProView is the way to read Thomson Reuters eBooks and eLooseleafs, published primarily for legal, accounting, human resources, and tax professions. The Thomson Reuters ProView web-based application is accessed via your browser. With the new ProView web-app, offline capability is now available from your browser. The web application has a responsive design and is compatible with desktop, laptop, and mobile devices.

 

Get started with ProView training

Select individual volumes or supplements that you want to purchase.
QuantityTitle/DescriptionFormatPublication dateAvailabilityPrice
GUIDE TO BIOSIMILARS LITIGATION AND REGULATION IN THE U.S. 2025-2026SupplementData unavailableIn stock$261.00

Related Resources

Publication Frequency:
As changes in the law dictate
Updated Format:
N/A

Goodwin

Goodwin is an AmLaw 50 law firm with more than 1,100 attorneys across the United States, Europe, and Asia. We excel at complex transactions, high stakes litigation, and world class advisory services in the life sciences, private equity, real estate,